Natural Alternatives International, Inc. (NAII) has reported 75.36 percent plunge in profit for the quarter ended Mar. 31, 2017. The company has earned $0.74 million, or $0.11 a share in the quarter, compared with $3.02 million, or $0.46 a share for the same period last year.

Revenue during the quarter dropped 16.23 percent to $25.14 million from $30.01 million in the previous year period. Gross margin for the quarter contracted 116 basis points over the previous year period to 20.36 percent. Total expenses were 96.05 percent of quarterly revenues, up from 89.65 percent for the same period last year. That has resulted in a contraction of 640 basis points in operating margin to 3.95 percent.

Operating income for the quarter was $0.99 million, compared with $3.10 million in the previous year period.

Mark A. Le Doux, chairman and chief executive officer stated, "The reduction in contract manufacturing requirements for the third fiscal quarter, primarily from the Asian and European markets was largely anticipated. Continued growth in other contract manufacturing markets, and in our CarnoSyn® division helped offset the decline. Our current quarter sales have seen a resurgence in demand from many of these areas, and our near-term growth expectations remain unchanged."